5th Circ. Weighs 'Very Complex' Chemo Hair Loss Dispute
The Fifth Circuit is weighing whether two drug manufacturers had an obligation to expedite changing the label on their chemotherapy medications to warn of permanent hair loss in a case one...To view the full article, register now.
Already a subscriber? Click here to view full article